多重用药与抗胆碱能负担量表之间关系的评估。
The evaluation of relationship between polypharmacy and anticholinergic burden scales.
作者信息
Okudur Saadet Koc, Dokuzlar Ozge, Aydin Ali Ekrem, Kocyigit Suleyman Emre, Soysal Pinar, Isik Ahmet Turan
机构信息
Department of Geriatric Medicine, Manisa State Hospital, Manisa, Turkey.
Department of Geriatric Medicine, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey.
出版信息
North Clin Istanb. 2021 Mar 11;8(2):139-144. doi: 10.14744/nci.2020.17136. eCollection 2021.
Abstract
OBJECTIVE
Polypharmacy and anticholinergic burden are the indicators for the evaluation of the quality of pharmacotherapy in older adults. The aim of this study was to consider which anticholinergic burden scales are more related with polypharmacy among older patients.
METHODS
Four hundred and twenty older adults were evaluated retrospectively in this cross-sectional study. The patient's demographic data, comorbidities, the drugs, and number of drugs were recorded. Anticholinergic burden scales were calculated by a tool named anticholinergic burden calculator.
RESULTS
The participants' mean age was 73.08±8.71. The prevalence of polypharmacy was 32.14%. The highest relationship with polypharmacy was observed for drug burden index (DBI) (odds ratio 10.87, p<0.001).
CONCLUSION
Our study demonstrated that polypharmacy and DBI scores were more related than other anticholinergic burden scales in older adults.
摘要
目的
多重用药和抗胆碱能负担是评估老年人药物治疗质量的指标。本研究的目的是探讨在老年患者中，哪些抗胆碱能负担量表与多重用药的相关性更强。
方法
在这项横断面研究中，对420名老年人进行了回顾性评估。记录了患者的人口统计学数据、合并症、所用药物及药物数量。使用一种名为抗胆碱能负担计算器的工具计算抗胆碱能负担量表。
结果
参与者的平均年龄为73.08±8.71岁。多重用药的患病率为32.14%。药物负担指数（DBI）与多重用药的相关性最高（优势比10.87，p<0.001）。
结论
我们的研究表明，在老年人中，多重用药与DBI评分的相关性比其他抗胆碱能负担量表更强。
相似文献
1
The evaluation of relationship between polypharmacy and anticholinergic burden scales.
North Clin Istanb. 2021 Mar 11;8(2):139-144. doi: 10.14744/nci.2020.17136. eCollection 2021.
2
Anticholinergic Exposure in Elderly Complex Chronic Patients: A Cross-Sectional Study.
Curr Pharm Des. 2021;27(40):4186-4194. doi: 10.2174/1381612827666210830164054.
3
Drug Burden Index in Older Adults with Psychiatric Illnesses: A Cross-Sectional Study.
Drugs Real World Outcomes. 2023 Jun;10(2):283-290. doi: 10.1007/s40801-023-00357-3. Epub 2023 Mar 13.
4
Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission.
Geriatr Gerontol Int. 2018 Aug;18(8):1159-1165. doi: 10.1111/ggi.13330. Epub 2018 Apr 11.
5
Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.
Int J Clin Pharm. 2019 Oct;41(5):1152-1158. doi: 10.1007/s11096-019-00885-5. Epub 2019 Aug 7.
6
Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models.
Drugs Aging. 2021 Nov;38(11):977-994. doi: 10.1007/s40266-021-00895-x. Epub 2021 Nov 9.
7
An Increased Anticholinergic Drug Burden Index Score Negatively Affect Nutritional Status in Older Patients Without Dementia.
Front Nutr. 2022 Feb 8;9:789986. doi: 10.3389/fnut.2022.789986. eCollection 2022.
8
[Effects of polypharmacy and anticholinergic/sedative drugs on the physical/cognitive/mental related outcomes of community-dwelling elderly people: The Kawasaki Wellbeing Project].
Nihon Ronen Igakkai Zasshi. 2019;56(4):504-515. doi: 10.3143/geriatrics.56.504.
9
Delirium is not associated with anticholinergic burden or polypharmacy in older patients on admission to an acute hospital: an observational case control study.
BMC Geriatr. 2016 Sep 21;16(1):162. doi: 10.1186/s12877-016-0336-9.
10
Associations of drug burden index with falls, general practitioner visits, and mortality in older people.
Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):753-8. doi: 10.1002/pds.3624. Epub 2014 Apr 10.
引用本文的文献
1
Multimorbidity, medications, and their association with falls, physical activity, and cognitive functions in older adults: multicenter study in Sri Lanka.
Sci Rep. 2025 Feb 20;15(1):6233. doi: 10.1038/s41598-025-91037-5.
2
Polypharmacy and anticholinergic burden scales in older adults: a cross-sectional study among psychiatric outpatients in a tertiary care hospital.
BMC Geriatr. 2025 Jan 20;25(1):43. doi: 10.1186/s12877-024-05584-z.
3
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada.
Ther Adv Drug Saf. 2024 Dec 25;15:20420986241309882. doi: 10.1177/20420986241309882. eCollection 2024.
4
Impact of the Anticholinergic Burden on Disease-Specific Symptoms in Parkinsonian Syndromes.
Brain Sci. 2024 Aug 11;14(8):805. doi: 10.3390/brainsci14080805.
5
Clinical pharmacist-led assessment and management of anticholinergic burden and fall risk in geriatric patients.
BMC Geriatr. 2023 Dec 15;23(1):863. doi: 10.1186/s12877-023-04599-2.
6
Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan.
Saudi Pharm J. 2023 Sep;31(9):101710. doi: 10.1016/j.jsps.2023.101710. Epub 2023 Jul 26.
7
Drug Burden Index in Older Adults with Psychiatric Illnesses: A Cross-Sectional Study.
Drugs Real World Outcomes. 2023 Jun;10(2):283-290. doi: 10.1007/s40801-023-00357-3. Epub 2023 Mar 13.
8
Association between Polypharmacy and Cardiovascular Autonomic Function among Elderly Patients in an Urban Municipality Area of Kolkata, India: A Record-Based Cross-Sectional Study.
Geriatrics (Basel). 2022 Nov 29;7(6):136. doi: 10.3390/geriatrics7060136.
9
Polypharmacy and Its Association with Dysphagia and Malnutrition among Stroke Patients with Sarcopenia.
Nutrients. 2022 Oct 12;14(20):4251. doi: 10.3390/nu14204251.
10
A novel Artificial Intelligence-based tool to assess anticholinergic burden: a survey.
Age Ageing. 2022 Aug 2;51(8). doi: 10.1093/ageing/afac196.
本文引用的文献
1
Comparative Analysis Of Anticholinergics Prescribed To Elderly Patients At A Korean Long-Term Care Facility According To Beers Criteria 2003, 2012, And 2015 And Anticholinergic-Burden Rating Scales: A Cross-Sectional Retrospective Study.
Clin Interv Aging. 2019 Nov 8;14:1963-1974. doi: 10.2147/CIA.S224434. eCollection 2019.
2
Frequency and coincidence of geriatric syndromes according to age groups: single-center experience in Turkey between 2013 and 2017.
Clin Interv Aging. 2018 Oct 4;13:1899-1905. doi: 10.2147/CIA.S180281. eCollection 2018.
3
Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews.
Drugs Aging. 2018 Jun;35(6):523-538. doi: 10.1007/s40266-018-0549-z.
4
Costs of medication in older patients: before and after comprehensive geriatric assessment.
Clin Interv Aging. 2018 Apr 9;13:607-613. doi: 10.2147/CIA.S159966. eCollection 2018.
5
Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from The English Longitudinal Study of Ageing (ELSA).
BMJ Open. 2018 Mar 14;8(3):e020270. doi: 10.1136/bmjopen-2017-020270.
6
Development of the Anticholinergic Burden Calculator Web Tool.
Farm Hosp. 2017 Sep 1;41(5):647-648. doi: 10.7399/fh.10799.
7
Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy.
Pharmacol Res Perspect. 2017 May 31;5(3):e00321. doi: 10.1002/prp2.321. eCollection 2017 Jun.
8
Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives.
Am J Geriatr Psychiatry. 2017 May;25(5):531-540. doi: 10.1016/j.jagp.2017.01.009. Epub 2017 Jan 23.
9
Systematic review on the use of anticholinergic scales in poly pathological patients.
Arch Gerontol Geriatr. 2016 Jan-Feb;62:1-8. doi: 10.1016/j.archger.2015.10.002. Epub 2015 Oct 14.
10
Concordance Between Anticholinergic Burden Scales.
J Am Geriatr Soc. 2015 Oct;63(10):2120-4. doi: 10.1111/jgs.13647.
Zotero 插件